Global Enteral Stents Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2025 –2032 |
 Marktgröße (Basisjahr) | USD 2.39 Billion |
 Marktgröße (Prognosejahr) | USD 3.89 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
Global Enteral Stents Market Segmentation, By Stent Type (Esophageal Stents, Gastroduodenal Stents, and Colon Stents), Product Type (Self-Expandable Metal Stents (SEMS) and Self-Expandable Plastic Stents (SEPS)), End User (Hospitals, Specialty Clinics, Ambulatory Centers, and Research Centers) – Industry Trends and Forecast to 2032
Enteral Stents Market Analysis
The enteral stents market has seen significant advancements in materials, design, and delivery techniques. Recent innovations include the development of biocompatible, self-expanding metal stents made from advanced alloys, which improve flexibility, strength, and biocompatibility. These stents are designed to resist clogging and migration, leading to better patient outcomes.
The introduction of biodegradable enteral stents is also a major leap forward. These stents degrade naturally after fulfilling their purpose, reducing the need for removal procedures and minimizing the risk of long-term complications. In addition, advances in imaging technology, such as endoscopic and fluoroscopic guidance, enable more precise placement of stents, enhancing their effectiveness.
The growth of the enteral stents market is driven by the rising prevalence of gastrointestinal disorders, such as esophageal cancer, and increasing awareness about minimally invasive treatments. As the aging population grows and healthcare providers focus on improving patient quality of life, the demand for enteral stents continues to rise. Enhanced technology and better treatment outcomes are expected to fuel further market growth in the coming years.
Enteral Stents Market Size
The global enteral stents market size was valued at USD 2.39 billion in 2024 and is projected to reach USD 3.89 billion by 2032, with a CAGR of 6.28% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Enteral Stents Market Trends
“Rising Demand for Minimally Invasive Procedures”
A key trend driving the growth of the enteral stents market is the increasing preference for minimally invasive procedures. Enteral stents, used to treat gastrointestinal blockages, are essential for providing relief without the need for extensive surgery. The growing awareness of these procedures' benefits, including shorter recovery times and reduced hospital stays, is fueling market demand. For instance, hospitals and clinics worldwide are adopting stent placement over surgical bypass procedures, as stents offer quicker, less traumatic options for patients with conditions such as esophageal cancer or Crohn's disease. This shift towards minimally invasive treatments is expected to accelerate the adoption of enteral stents, significantly contributing to market expansion.
Report Scope and Enteral Stents Market Segmentation
|
Attributes |
Enteral Stents Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Boston Scientific Corporation (U.S.), Cook (U.S.), Abbott (U.S.), Biosensors International Group, Ltd. (Singapore), Stryker (U.S.), Medtronic (U.S.), B. Braun SE (Germany), BD (U.S.), Cardinal Health (U.S.), Terumo Europe NV (Belgium), TAEWOONG (South Korea), ELLA - CS, s.r.o. (Czech Republic), Merit Medical Systems (U.S.), M.I.TECH. (South Korea), BVM Medical Limited (U.K.), Changzhou Health Microport Medical Device Co., LTD. (China), ENDO-FLEX GmbH (Germany), Micro-Tech (Nanjing) Co., Ltd. (China), and GBUK Group Ltd. (U.K.) |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Enteral Stents Market Definition
Enteral stents are medical devices used to treat blockages or strictures in the digestive tract, including the esophagus, duodenum, or colon. They are typically made from materials such as metal or silicone and are designed to be inserted into the affected area to keep the passage open. This helps maintain the flow of food, fluids, or waste, improving the patient's ability to eat and digest. Enteral stents are often used in patients with conditions such as cancer, Crohn's disease, or other gastrointestinal disorders, offering a less invasive alternative to surgery and improving overall quality of life.
Enteral Stents Market Dynamics
Drivers
- Increasing Prevalence of Gastrointestinal Diseases
The increasing prevalence of gastrointestinal diseases, such as colorectal cancer, esophageal cancer, and Crohn’s disease, is a significant driver of the enteral stents market. These conditions often lead to obstructions in the digestive tract, requiring interventions to restore proper passage for food and fluids. For instance, in patients with esophageal cancer, where tumors can block the esophagus, enteral stents are used to maintain a clear passage for swallowing, improving patient quality of life. Similarly, in colorectal cancer or Crohn’s disease, stents are used to alleviate symptoms and avoid surgical procedures. As these diseases rise globally, the demand for enteral stents as a non-surgical solution continues to grow, boosting market expansion.
- Rising Demand for Palliative Care
The growing focus on palliative care, particularly in oncology, is driving the enteral stents market. Enteral stents are commonly used to manage symptoms in terminal cancer patients, such as relieving esophageal or gastrointestinal obstructions. This palliative approach helps improve the quality of life for patients who are not candidates for curative surgery. For instance, in patients with advanced esophageal cancer, self-expanding metal stents are frequently used to restore swallowing function, offering symptom relief. The increasing recognition of the importance of palliative care in cancer treatment, coupled with the aging population and rising cancer rates, significantly contributes to the rising demand for enteral stents in this setting.
Opportunities
- Advancements in Stent Materials
The development of biocompatible and durable materials has created significant opportunities in the enteral stents market. Innovations such as self-expanding metal stents (SEMS) made from alloys such as nitinol offer superior flexibility, durability, and resistance to corrosion. In addition, the emergence of biodegradable stents made from materials such as polylactic acid (PLA) provides a temporary solution, reducing the need for removal procedures. These advancements not only enhance the effectiveness of stents but also minimize complications such as infection and blockage. For instance, the use of coated stents in treating esophageal cancer has improved outcomes by reducing tumor ingrowth and migration, thereby increasing the market demand for such advanced stent technologies.
- Government Initiatives for Cancer Treatment
Government initiatives aimed at improving cancer care are creating significant opportunities in the enteral stents market. With an increasing focus on offering better treatment options, many governments have been funding advanced therapies for cancer patients, including minimally invasive solutions such as enteral stents. For instance, According to the World Health Organization 2023, colorectal cancer is the third most common cancer, responsible for about 10% of all cases and the second leading cause of cancer-related deaths worldwide. The Global Cancer Observatory reported nearly 1.15 million new cases in 2020, with projections estimating around 1.92 million new cases globally by 2040.
Restraints/Challenges
- Cost and Reimbursement Issues
Cost and reimbursement issues significantly hinder the enteral stents market. The high cost of these devices can be a major barrier, particularly in healthcare systems with limited budgets or price-sensitive populations. In many regions, reimbursement policies for enteral stents are restrictive or inadequate, leading to patients being unable to afford the procedure. Healthcare systems may not fully cover the expenses, forcing patients to either bear the cost themselves or forgo treatment altogether. This results in reduced adoption rates, limiting the growth potential of the market. In addition, hospitals and healthcare providers may be hesitant to invest in expensive stents without adequate financial support or reimbursement assurances.
- Chances of Complications and Risks
The chances of complications and risks associated with enteral stents significantly hinder market growth. Migration of stents, perforation of the gastrointestinal tract, and infections are common issues that can arise after stent placement. These complications often necessitate additional medical interventions, leading to longer hospital stays and increased healthcare costs. Furthermore, the need for follow-up procedures or removal of the stents can contribute to patient discomfort and prolong recovery times. Such risks deter both healthcare providers and patients from opting for enteral stents, leading to a decline in adoption rates. As a result, these complications pose a substantial challenge to the growth of the enteral stents market.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Enteral Stents Market Scope
The market is segmented on the basis of product type, stent type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Stent Type
- Esophageal Stents
- Gastroduodenal Stents
- Colon Stents
- Pre-Operative Decompression
- Palliation of Advanced Malignancy
Product Type
- Self-Expandable Metal Stents (SEMS)
- Uncovered SEMS
- Partially Covered SEMS
- Fully Covered SEMS
- Self-Expandable Plastic Stents (SEPS)
End User
- Hospitals
- Specialty Clinics
- Ambulatory Centers
- Research Centers
Enteral Stents Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, product type, stent type and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
North America is expected to dominate the enteral stents market due to technological advancements, a rising prevalence of cancer, and lifestyle changes in the region. The growing demand for minimally invasive procedures and improved healthcare infrastructure further boosts the adoption of enteral stents, positioning North America as the leading market player.
Asia-Pacific is expected to grow at the highest growth rate in the enteral stents market during the forecast period. This growth is driven by advancements in healthcare infrastructure, increasing per capita healthcare expenditure, and rising demand for minimally invasive procedures, particularly in countries such as China and India.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Enteral Stents Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Enteral Stents Market Leaders Operating in the Market Are:
- Boston Scientific Corporation (U.S.)
- Cook (U.S.)
- Abbott (U.S.)
- Biosensors International Group, Ltd. (Singapore)
- Stryker (U.S.)
- Medtronic (U.S.)
- B. Braun SE (Germany)
- BD (U.S.)
- Cardinal Health (U.S.)
- Terumo Europe NV (Belgium)
- TAEWOONG (South Korea)
- ELLA - CS, s.r.o. (Czech Republic)
- Merit Medical Systems (U.S.)
- M.I.TECH. (South Korea)
- BVM Medical Limited (U.K.)
- Changzhou Health Microport Medical Device Co., LTD. (China)
- ENDO-FLEX GmbH (Germany)
- Micro-Tech (Nanjing) Co., Ltd. (China)
- GBUK Group Ltd. (U.K.)
Latest Developments in Enteral Stents Market
- In November 2022, The Union Health Ministry of India announced the inclusion of coronary stents in the National List of Essential Medicines 2022. This decision was aimed at making coronary stents more affordable for the Indian population, thereby improving access to life-saving treatments for heart conditions and enhancing overall cardiovascular care across the country
- In May 2022, Medtronic received approval from the US FDA for the Onyx Frontier drug-eluting stent (DES), a significant advancement in cardiovascular treatment. This stent features a unique design to enhance the safety and effectiveness of heart procedures, offering improved clinical outcomes for patients suffering from coronary artery disease, with a focus on long-term performance
- In April 2022, Translumina, a prominent manufacturer of cardiovascular medical devices, launched its innovative VIVO ISAR dual drug polymer-free coated stent (DDCS) in international markets, including Europe. The stent offers improved drug delivery and vascular healing, providing an alternative to traditional drug-eluting stents and enhancing treatment options for patients undergoing interventional cardiology procedures globally
- In October 2020, Olympus, a leader in medical technologies, launched the HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS) in the US. Manufactured by M.I. Tech and distributed exclusively through Olympus, these stents are designed for treating esophageal conditions, offering a reliable solution for physicians to manage obstructive and malignant conditions in the esophagus, improving patient care and quality of life
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
